{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:29:13Z","timestamp":1792704553016,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,16]],"date-time":"2012-10-16T00:00:00Z","timestamp":1350345600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2407-12-478","type":"journal-article","created":{"date-parts":[[2012,10,16]],"date-time":"2012-10-16T22:14:17Z","timestamp":1350425657000},"source":"Crossref","is-referenced-by-count":25,"title":["Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma"],"prefix":"10.1186","volume":"12","author":[{"given":"Egil S","family":"Blix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M","family":"Irish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Husebekk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Delabie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Forfang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M","family":"Tierens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June H","family":"Myklebust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Kolstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,16]]},"reference":[{"issue":"1","key":"3474_CR1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrc2764","volume":"10","author":"T Zenz","year":"2010","unstructured":"Zenz T, Mertens D, Kuppers R, Dohner H, Stilgenbauer S: From pathogenesis to treatment of chronic lymphocytic leukaemia. Nat Rev Cancer. 2010, 10 (1): 37-50.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"3474_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrc1589","volume":"5","author":"R Kuppers","year":"2005","unstructured":"Kuppers R: Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer. 2005, 5 (4): 251-262. 10.1038\/nrc1589.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"3474_CR3","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/nri955","volume":"2","author":"H Niiro","year":"2002","unstructured":"Niiro H, Clark EA: Regulation of B-cell fate by antigen-receptor signals. Nat Rev Immunol. 2002, 2 (12): 945-956. 10.1038\/nri955.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"3474_CR4","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/j.1460-2075.1994.tb06387.x","volume":"13","author":"M Takata","year":"1994","unstructured":"Takata M, Sabe H, Hata A, Inazu T, Homma Y, Nukada T, Yamamura H, Kurosaki T: Tyrosine kinases Lyn and Syk regulate B cell receptor-coupled Ca2+ mobilization through distinct pathways. EMBO J. 1994, 13 (6): 1341-1349.","journal-title":"EMBO J"},{"issue":"1","key":"3474_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1600-065X.2010.00944.x","volume":"237","author":"F Mackay","year":"2010","unstructured":"Mackay F, Figgett WA, Saulep D, Lepage M, Hibbs ML: B-cell stage and context-dependent requirements for survival signals from BAFF and the B-cell receptor. Immunol Rev. 2010, 237 (1): 205-225. 10.1111\/j.1600-065X.2010.00944.x.","journal-title":"Immunol Rev"},{"issue":"6","key":"3474_CR6","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.semcancer.2010.08.004","volume":"20","author":"G Packham","year":"2010","unstructured":"Packham G, Stevenson F: The role of the B-cell receptor in the pathogenesis of chronic lymphocytic leukaemia. Semin Cancer Biol. 2010, 20 (6): 391-399. 10.1016\/j.semcancer.2010.08.004.","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"3474_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nrclinonc.2009.72","volume":"6","author":"L Pleyer","year":"2009","unstructured":"Pleyer L, Egle A, Hartmann TN, Greil R: Molecular and cellular mechanisms of CLL: novel therapeutic approaches. Nat Rev Clin Oncol. 2009, 6 (7): 405-418. 10.1038\/nrclinonc.2009.72.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"3474_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1600-065X.2010.00932.x","volume":"237","author":"JP Graham","year":"2010","unstructured":"Graham JP, Arcipowski KM, Bishop GA: Differential B-lymphocyte regulation by CD40 and its viral mimic, latent membrane protein 1. Immunol Rev. 2010, 237 (1): 226-248. 10.1111\/j.1600-065X.2010.00932.x.","journal-title":"Immunol Rev"},{"issue":"4","key":"3474_CR9","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1084\/jem.177.4.925","volume":"177","author":"EA Ranheim","year":"1993","unstructured":"Ranheim EA, Kipps TJ: Activated T cells induce expression of B7\/BB1 on normal or leukemic B cells through a CD40-dependent signal. J Exp Med. 1993, 177 (4): 925-935. 10.1084\/jem.177.4.925.","journal-title":"J Exp Med"},{"issue":"10","key":"3474_CR10","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.4049\/jimmunol.153.10.4357","volume":"153","author":"I Berberich","year":"1994","unstructured":"Berberich I, Shu G, Clark E: Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B. J Immunol. 1994, 153 (10): 4357-4366.","journal-title":"J Immunol"},{"issue":"4","key":"3474_CR11","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1084\/jem.177.4.1215","volume":"177","author":"AC Lalmanach-Girard","year":"1993","unstructured":"Lalmanach-Girard AC, Chiles TC, Parker DC, Rothstein TL: T cell-dependent induction of NF-kappa B in B cells. J Exp Med. 1993, 177 (4): 1215-1219. 10.1084\/jem.177.4.1215.","journal-title":"J Exp Med"},{"issue":"8","key":"3474_CR12","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/sj.leu.2403398","volume":"18","author":"S Cuni","year":"2004","unstructured":"Cuni S, Perez-Aciego P, Perez-Chacon G, Vargas JA, Sanchez A, Martin-Saavedra FM, Ballester S, Garcia-Marco J, Jorda J, Durantez A: A sustained activation of PI3K\/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells. Leukemia. 2004, 18 (8): 1391-1400. 10.1038\/sj.leu.2403398.","journal-title":"Leukemia"},{"issue":"13","key":"3474_CR13","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1182\/blood-2004-02-0494","volume":"104","author":"CS Gricks","year":"2004","unstructured":"Gricks CS, Zahrieh D, Zauls AJ, Gorgun G, Drandi D, Mauerer K, Neuberg D, Gribben JG: Differential regulation of gene expression following CD40 activation of leukemic compared to healthy B cells. Blood. 2004, 104 (13): 4002-4009. 10.1182\/blood-2004-02-0494.","journal-title":"Blood"},{"issue":"4","key":"3474_CR14","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/j.1365-2141.2004.05225.x","volume":"127","author":"AP Kater","year":"2004","unstructured":"Kater AP, Evers LM, Remmerswaal EBM, Jaspers A, Oosterwijk MF, van Lier RAW, van Oers MHJ, Eldering E: CD40 stimulation of B-cell chronic lymphocytic leukaemia cells enhances the anti-apoptotic profile, but also Bid expression and cells remain susceptible to autologous cytotoxic T-lymphocyte attack. Br J Haematol. 2004, 127 (4): 404-415. 10.1111\/j.1365-2141.2004.05225.x.","journal-title":"Br J Haematol"},{"issue":"3","key":"3474_CR15","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1182\/blood.V92.3.990","volume":"92","author":"MF Romano","year":"1998","unstructured":"Romano MF, Lamberti A, Tassone P, Alfinito F, Costantini S, Chiurazzi F, Defrance T, Bonelli P, Tuccillo F, Turco MC, et al: Triggering of CD40 Antigen Inhibits Fludarabine-Induced Apoptosis in B Chronic Lymphocytic Leukemia Cells. Blood. 1998, 92 (3): 990-995.","journal-title":"Blood"},{"issue":"8","key":"3474_CR16","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.4049\/jimmunol.157.8.3381","volume":"157","author":"C Sutherland","year":"1996","unstructured":"Sutherland C, Heath A, Pelech S, Young P, Gold M: Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor. J Immunol. 1996, 157 (8): 3381-3390.","journal-title":"J Immunol"},{"issue":"3","key":"3474_CR17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/sj.leu.2402389","volume":"16","author":"T Decker","year":"2002","unstructured":"Decker T, Schneller F, Hipp S, Miething C, Jahn T, Duyster J, Peschel C: Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27. Leukemia. 2002, 16 (3): 327-334. 10.1038\/sj.leu.2402389.","journal-title":"Leukemia"},{"issue":"2","key":"3474_CR18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1182\/blood.V67.2.279.279","volume":"67","author":"O Ayanlar-Batuman","year":"1986","unstructured":"Ayanlar-Batuman O, Ebert E, Hauptman S: Defective interleukin-2 production and responsiveness by T cells in patients with chronic lymphocytic leukemia of B cell variety. Blood. 1986, 67 (2): 279-284.","journal-title":"Blood"},{"issue":"5","key":"3474_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1034\/j.1600-0609.2002.01612.x","volume":"68","author":"ED Rossmann","year":"2002","unstructured":"Rossmann ED, Lewin N, Jeddi-Tehrani M, Osterborg A, Mellstedt H: Intracellular T cell cytokines in patients with B cell chronic lymphocytic leukaemia (B-CLL). Eur J Haematol. 2002, 68 (5): 299-306. 10.1034\/j.1600-0609.2002.01612.x.","journal-title":"Eur J Haematol"},{"issue":"3","key":"3474_CR20","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.4049\/jimmunol.177.3.1581","volume":"177","author":"JM Irish","year":"2006","unstructured":"Irish JM, Czerwinski DK, Nolan GP, Levy R: Kinetics of B cell receptor signaling in human B cell subsets mapped by phosphospecific flow cytometry. J Immunol. 2006, 177 (3): 1581-1589.","journal-title":"J Immunol"},{"issue":"9","key":"3474_CR21","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1182\/blood-2006-02-003921","volume":"108","author":"JM Irish","year":"2006","unstructured":"Irish JM, Czerwinski DK, Nolan GP, Levy R: Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells. Blood. 2006, 108 (9): 3135-3142. 10.1182\/blood-2006-02-003921.","journal-title":"Blood"},{"issue":"29","key":"3474_CR22","doi-asserted-by":"publisher","first-page":"12747","DOI":"10.1073\/pnas.1002057107","volume":"107","author":"JM Irish","year":"2010","unstructured":"Irish JM, Myklebust JH, Alizadeh AA, Houot R, Sharman JP, Czerwinski DK, Nolan GP, Levy R: B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression. Proc Natl Acad Sci U S A. 2010, 107 (29): 12747-12754. 10.1073\/pnas.1002057107.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"3474_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/cyto.a.10072","volume":"55A","author":"PO Krutzik","year":"2003","unstructured":"Krutzik PO, Nolan GP: Intracellular phospho-protein staining techniques for flow cytometry: Monitoring single cell signaling events. Cytometry A. 2003, 55A (2): 61-70. 10.1002\/cyto.a.10072.","journal-title":"Cytometry A"},{"issue":"2","key":"3474_CR24","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/nrc1804","volume":"6","author":"JM Irish","year":"2006","unstructured":"Irish JM, Kotecha N, Nolan GP: Mapping normal and cancer cell signalling networks: towards single-cell proteomics. Nat Rev Cancer. 2006, 6 (2): 146-155. 10.1038\/nrc1804.","journal-title":"Nat Rev Cancer"},{"key":"3474_CR25","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissue","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, International Agency for Research on Cancer: WHO classification of tumours of haematopoietic and lymphoid tissue. 2008, Lyon: IARC, 4","edition":"4"},{"issue":"5","key":"3474_CR26","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nmeth872","volume":"3","author":"PO Krutzik","year":"2006","unstructured":"Krutzik PO, Nolan GP: Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling. Nat Methods. 2006, 3 (5): 361-368. 10.1038\/nmeth872.","journal-title":"Nat Methods"},{"key":"3474_CR27","unstructured":"Cluster 3.0. http:\/\/bonsai.hgc.jp\/~mdehoon\/software\/cluster\/software.htm ,"},{"key":"3474_CR28","unstructured":"Java TreeView. http:\/\/jtreeview.sourceforge.net\/ ,"},{"issue":"12","key":"3474_CR29","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.1182\/blood-2004-07-2669","volume":"105","author":"A Petlickovski","year":"2005","unstructured":"Petlickovski A, Laurenti L, Li X, Marietti S, Chiusolo P, Sica S, Leone G, Efremov DG: Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells. Blood. 2005, 105 (12): 4820-4827. 10.1182\/blood-2004-07-2669.","journal-title":"Blood"},{"issue":"21","key":"3474_CR30","first-page":"2830","volume":"116","author":"A Younes","year":"2010","unstructured":"Younes A, Fanale MA, McLaughlin P, Copeland A, Zhu J, de Castro Faria S: Phase I Study of a Novel Oral JAK-2 Inhibitor SB1518 In Patients with Relapsed Lymphoma: Evidence of Clinical and Biologic Activity In Multiple Lymphoma Subtypes. ASH Annual Meeting Abstracts. 2010, 116 (21): 2830-","journal-title":"ASH Annual Meeting Abstracts"},{"issue":"11","key":"3474_CR31","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1038\/leu.2011.148","volume":"25","author":"S Hart","year":"2011","unstructured":"Hart S, Goh KC, Novotny-Diermayr V, Hu CY, Hentze H, Tan YC, Madan B, Amalini C, Loh YK, Ong LC, et al: SB1518, a novel macrocyclic pyrimidine-based JAK2 inhibitor for the treatment of myeloid and lymphoid malignancies. Leukemia. 2011, 25 (11): 1751-1759. 10.1038\/leu.2011.148.","journal-title":"Leukemia"},{"issue":"1","key":"3474_CR32","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1182\/blood-2007-09-111344","volume":"112","author":"M Muzio","year":"2008","unstructured":"Muzio M, Apollonio B, Scielzo C, Frenquelli M, Vandoni I, Boussiotis V, Caligaris-Cappio F, Ghia P: Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy. Blood. 2008, 112 (1): 188-195. 10.1182\/blood-2007-09-111344.","journal-title":"Blood"},{"issue":"5","key":"3474_CR33","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/leu.2008.21","volume":"22","author":"A Poggi","year":"2008","unstructured":"Poggi A, Catellani S, Bruzzone A, Caligaris-Cappio F, Gobbi M, Zocchi MR: Lack of the leukocyte-associated Ig-like receptor-1 expression in high-risk chronic lymphocytic leukaemia results in the absence of a negative signal regulating kinase activation and cell division. Leukemia. 2008, 22 (5): 980-988. 10.1038\/leu.2008.21.","journal-title":"Leukemia"},{"issue":"2","key":"3474_CR34","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1172\/JCI200522094","volume":"115","author":"A Contri","year":"2005","unstructured":"Contri A, Brunati AM, Trentin L, Cabrelle A, Miorin M, Cesaro L, Pinna LA, Zambello R, Semenzato G, Donella-Deana A: Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis. J Clin Invest. 2005, 115 (2): 369-378.","journal-title":"J Clin Invest"},{"issue":"4","key":"3474_CR35","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/leu.2008.346","volume":"23","author":"S Gobessi","year":"2009","unstructured":"Gobessi S, Laurenti L, Longo PG, Carsetti L, Berno V, Sica S, Leone G, Efremov DG: Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells. Leukemia. 2009, 23 (4): 686-697. 10.1038\/leu.2008.346.","journal-title":"Leukemia"},{"issue":"3","key":"3474_CR36","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1182\/blood-2002-06-1822","volume":"101","author":"S Lanham","year":"2003","unstructured":"Lanham S, Hamblin T, Oscier D, Ibbotson R, Stevenson F, Packham G: Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia. Blood. 2003, 101 (3): 1087-1093. 10.1182\/blood-2002-06-1822.","journal-title":"Blood"},{"issue":"13","key":"3474_CR37","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1182\/blood-2009-08-236471","volume":"115","author":"JW Friedberg","year":"2010","unstructured":"Friedberg JW, Sharman J, Sweetenham J, Johnston PB, Vose JM, LaCasce A, Schaefer-Cutillo J, De Vos S, Sinha R, Leonard JP, et al: Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia. Blood. 2010, 115 (13): 2578-2585. 10.1182\/blood-2009-08-236471.","journal-title":"Blood"},{"issue":"12","key":"3474_CR38","first-page":"1966","volume":"10","author":"AP Zomas","year":"1996","unstructured":"Zomas AP, Matutes E, Morilla R, Owusu-Ankomah K, Seon BK, Catovsky D: Expression of the immunoglobulin-associated protein B29 in B cell disorders with the monoclonal antibody SN8 (CD79b). Leukemia. 1996, 10 (12): 1966-1970.","journal-title":"Leukemia"},{"issue":"2","key":"3474_CR39","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.yexmp.2005.04.009","volume":"79","author":"RE Lewis","year":"2005","unstructured":"Lewis RE, Cruse JM, Pierce S, Lam J, Tadros Y: Surface and cytoplasmic immunoglobulin expression in B-cell chronic lymphocytic leukemia (CLL). Exp Mol Pathol. 2005, 79 (2): 146-150. 10.1016\/j.yexmp.2005.04.009.","journal-title":"Exp Mol Pathol"},{"issue":"6","key":"3474_CR40","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/j.1365-2141.2005.05699.x","volume":"130","author":"S Minuzzo","year":"2005","unstructured":"Minuzzo S, Indraccolo S, Tosello V, Piovan E, Cabrelle A, Trentin L, Semenzato G, Amadori A: Heterogeneous intracellular expression of B-cell receptor components in B-cell chronic lymphocytic leukaemia (B-CLL) cells and effects of CD79b gene transfer on surface immunoglobulin levels in a B-CLL-derived cell line. Br J Haematol. 2005, 130 (6): 878-889. 10.1111\/j.1365-2141.2005.05699.x.","journal-title":"Br J Haematol"},{"issue":"7","key":"3474_CR41","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1182\/blood-2004-09-3643","volume":"105","author":"F Vuillier","year":"2005","unstructured":"Vuillier F, Dumas G, Magnac C, Prevost M-C, Lalanne AI, Oppezzo P, Melanitou E, Dighiero G, Payelle-Brogard B: Lower levels of surface B-cell-receptor expression in chronic lymphocytic leukemia are associated with glycosylation and folding defects of the micro and CD79a chains. Blood. 2005, 105 (7): 2933-2940. 10.1182\/blood-2004-09-3643.","journal-title":"Blood"},{"issue":"3","key":"3474_CR42","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1182\/blood-2007-12-127688","volume":"112","author":"A Guarini","year":"2008","unstructured":"Guarini A, Chiaretti S, Tavolaro S, Maggio R, Peragine N, Citarella F, Ricciardi MR, Santangelo S, Marinelli M, De Propris MS, et al: BCR ligation induced by IgM stimulation results in gene expression and functional changes only in IgV H unmutated chronic lymphocytic leukemia (CLL) cells. Blood. 2008, 112 (3): 782-792. 10.1182\/blood-2007-12-127688.","journal-title":"Blood"},{"issue":"10","key":"3474_CR43","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.1182\/blood-2006-11-056648","volume":"109","author":"C Ian Mockridge","year":"2007","unstructured":"Ian Mockridge C, Potter KN, Wheatley I, Neville LA, Packham G, Stevenson FK: Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status. Blood. 2007, 109 (10): 4424-4431. 10.1182\/blood-2006-11-056648.","journal-title":"Blood"},{"issue":"5","key":"3474_CR44","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1182\/blood-2006-12-062265","volume":"111","author":"L Chen","year":"2008","unstructured":"Chen L, Huynh L, Apgar J, Tang L, Rassenti L, Weiss A, Kipps TJ: ZAP-70 enhances IgM signaling independent of its kinase activity in chronic lymphocytic leukemia. Blood. 2008, 111 (5): 2685-2692. 10.1182\/blood-2006-12-062265.","journal-title":"Blood"},{"issue":"4","key":"3474_CR45","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1600-0609.1998.tb01713.x","volume":"61","author":"N Laytragoon-Lewin","year":"1998","unstructured":"Laytragoon-Lewin N, Duhony E, Bai XF, Mellstedt H: Downregulation of the CD95 receptor and defect CD40-mediated signal transduction in B-chronic lymphocytic leukemia cells. Eur J Haematol. 1998, 61 (4): 266-271.","journal-title":"Eur J Haematol"},{"issue":"4","key":"3474_CR46","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1182\/blood.V99.4.1314","volume":"99","author":"IM Pedersen","year":"2002","unstructured":"Pedersen IM, Buhl AM, Klausen P, Geisler CH, Jurlander J: The chimeric anti-CD20 antibody rituximab induces apoptosis in B-cell chronic lymphocytic leukemia cells through a p38 mitogen activated protein-kinase-dependent mechanism. Blood. 2002, 99 (4): 1314-1319. 10.1182\/blood.V99.4.1314.","journal-title":"Blood"},{"issue":"6","key":"3474_CR47","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/onc.2010.441","volume":"30","author":"SH Tonino","year":"2011","unstructured":"Tonino SH, van Laar J, van Oers MH, Wang JY, Eldering E, Kater AP: ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia. Oncogene. 2011, 30 (6): 701-713. 10.1038\/onc.2010.441.","journal-title":"Oncogene"},{"issue":"9","key":"3474_CR48","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.1182\/blood-2007-11-125278","volume":"111","author":"S Hewamana","year":"2008","unstructured":"Hewamana S, Alghazal S, Lin TT, Clement M, Jenkins C, Guzman ML, Jordan CT, Neelakantan S, Crooks PA, Burnett AK, et al: The NF-kappaB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target. Blood. 2008, 111 (9): 4681-4689. 10.1182\/blood-2007-11-125278.","journal-title":"Blood"},{"issue":"17","key":"3474_CR49","doi-asserted-by":"crossref","first-page":"7800","DOI":"10.1158\/0008-5472.CAN-04-4180","volume":"65","author":"P Wlodarski","year":"2005","unstructured":"Wlodarski P, Kasprzycka M, Liu X, Marzec M, Robertson ES, Slupianek A, Wasik MA: Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase\/extracellular signal-regulated kinase kinase, insulin growth factor-I, and serum. Cancer Res. 2005, 65 (17): 7800-7808.","journal-title":"Cancer Res"},{"issue":"10","key":"3474_CR50","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1002\/eji.200737281","volume":"37","author":"AC Donahue","year":"2007","unstructured":"Donahue AC, Fruman DA: Distinct signaling mechanisms activate the target of rapamycin in response to different B-cell stimuli. Eur J Immunol. 2007, 37 (10): 2923-2936. 10.1002\/eji.200737281.","journal-title":"Eur J Immunol"},{"issue":"9","key":"3474_CR51","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/cncr.25005","volume":"116","author":"CS Zent","year":"2010","unstructured":"Zent CS, LaPlant BR, Johnston PB, Call TG, Habermann TM, Micallef IN, Witzig TE: The treatment of recurrent\/refractory chronic lymphocytic leukemia\/small lymphocytic lymphoma (CLL) with everolimus results in clinical responses and mobilization of CLL cells into the circulation. Cancer. 2010, 116 (9): 2201-2207.","journal-title":"Cancer"},{"issue":"7","key":"3474_CR52","first-page":"2427","volume":"118","author":"AG Ramsay","year":"2008","unstructured":"Ramsay AG, Johnson AJ, Lee AM, Gorgun G, Le Dieu R, Blum W, Byrd JC, Gribben JG: Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug. J Clin Invest. 2008, 118 (7): 2427-2437.","journal-title":"J Clin Invest"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-478.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-12-478\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-478","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T09:08:06Z","timestamp":1714468086000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-12-478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,16]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["3474"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-12-478","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,16]]},"article-number":"478"}}